메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Kim, Hwan-Mook (Bioevaluation Center, Korea Research Institute of Bioscience and Biotechnology [KRIBB]) Kang, Jong-Soon (Bioevaluation Center, Korea Research Institute of Bioscience and Biotechnology [KRIBB]) Lim, Jae-Seung (Innocell Ltd.) Park, Song-Kyu (Bioevaluation Center, Korea Research Institute of Bioscience and Biotechnology [KRIBB]) Lee, Ki-Ho (Bioevaluation Center, Korea Research Institute of Bioscience and Biotechnology [KRIBB]) Yoon, Yeo-Dae (Bioevaluation Center, Korea Research Institute of Bioscience and Biotechnology [KRIBB]) Lee, Chang-Woo (Bioevaluation Center, Korea Research Institute of Bioscience and Biotechnology [KRIBB]) Lee, Ki-Hoon (Bioevaluation Center, Korea Research Institute of Bioscience and Biotechnology [KRIBB]) Han, Gyoon-Hee (Department of Biotechnology, Yonsei University) Yang, Kyu-Hwan (Kyungwon University) Kim, Yeon-Jin (College of Pharmacy and CBITRC, Chungbuk National University) Kim, Young-Soo (College of Pharmacy and CBITRC, Chungbuk National University) Han, Sang-Bae (Bioevaluation Center, Korea Research Institute of Bioscience and Biotechnology [KRIBB])
저널정보
대한약학회 Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea 제30권 제11호
발행연도
2007.1
수록면
1,464 - 1,470 (7page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Despite the recent improvement in the treatment of ovarian cancer, this disease is still leading cause of cancer death in women. In this study, the anti-tumor activity of cytokine-induced killer (CIK) cells against human ovarian cancer was evaluated in vitro and in vivo. Although $CD3^+CD56^+$ cells were rare in fresh human peripheral blood mononuclear cells, they could expand more than 1,000-fold on day 14 in the presence of anti-CD3 antibody plus IL-2. At an effector-target cell ratio of 30:1, CIK cells destroyed 45% of SK-OV-3 human ovarian cancer cells, which was determined by the $^{51}Cr-release$ assay. In addition, CIK cells at a dose of 23 million cells per mouse inhibited 73% of SK-OV-3 tumor growth in nude mouse xenograft assay. This study suggests that CIK cells may be used as an adoptive immunotherapy for patients with ovarian cancer.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0